CONTENTS:
- Pre-registration: not a daunting practice [Editorial]. Marsden J., Cousijn J., Stapleton J., p. 845-846.
- Smoking cessation interventions for pregnant women attending treatment for substance use disorders: A systematic review. Jackson M.A., Baker A.L., Gould G.S., Brown A.L., Dunlop A.J., McCarter K., p. 847-860.
- Comparative clinical effectiveness and safety of tobacco cessation pharmacotherapies and electronic cigarettes: a systematic review and network meta-analysis of randomized controlled trials. Thomas K.H., Dalili M.N., Lopez-Lopez J.A., Keeney E., Phillippo D.M., Munafo M.R., et al., p. 861-876.
- Effects of brief substance use interventions delivered in general medical settings: a systematic review and meta-analysis. Tanner-Smith E.E., Parr N.J., Schweer-Collins M., Saitz R., p. 877-889.
- Commentary on Tanner-Smith et al.: Complexity matters-why we need to move beyond 'what works' when evaluating substance use interventions. O'Donnell A.J., p. 890-891.
- Behavioral response bias and event-related brain potentials implicate elevated incentive salience attribution to alcohol cues in emerging adults with lower sensitivity to alcohol. Cofresi R.U., Kohen C.B., Motschman C.A., Wiers R.W., Piasecki T.M., Bartholow B.D., p. 892-904.
- Risk of somatic disease and mortality in individuals of parents with alcohol use disorder: a register-based cohort study. Holst C., Tolstrup J.S., Becker U., p. 905-912.
- Employment trajectories among those treated for alcohol use disorder: A register-based cohort study. Christiansen S.G., Moan I.S., p. 913-924.
- External validation of a machine learning classifier to identify unhealthy alcohol use in hospitalized patients. Lin Y., Sharma B., Thompson H.M., Boley R., Perticone K., Chhabra N., et al., p. 925-933.
- Influence of alcohol and acetaldehyde on cognitive function: findings from an alcohol clamp study in healthy young adults. Ueno F., Matsushita S., Hara S., Oshima S., Roh S., Ramchandani V.A., et al., p. 934-945.
- Association between discontinuing chronic opioid therapy and newly diagnosed substance use disorders, accidents, self-inflicted injuries and drug overdoses within the prescribers' health care system: a retrospective cohort study. Hayes C.J., Krebs E.E., Li C., Brown J., Hudson T., Martin B.C., p. 946-968.
- Effect of reductions in opioid prescribing on opioid use disorder and fatal overdose in the United States: a dynamic Markov model. Alexander G.C., Ballreich J., Mansour O., Dowdy D.W., p. 969-976.
- Organ pathologies detected post-mortem in patients receiving opioid agonist treatment for opioid use disorder: a nation-wide 2-year cross-sectional study. Bech A.B., Clausen T., Waal H., Delaveris G.J.M., Skeie I., p. 977-985.
- Health impacts of a scale-up of supervised injection services in a Canadian setting: an interrupted time series analysis. Kennedy M.C., Hayashi K., Milloy M.J., Compton M., Kerr T., p. 986-997.
- Patient characteristics and treatment utilization in fatal stimulant-involved overdoses in the United States Veterans Health Administration. Coughlin L.N., Zhang L., Bohnert A.S.B., Maust D.T., Goldstick J., Lin L.A., p. 998-1008.
- The cost and impact of distributing naloxone to people who are prescribed opioids to prevent opioid-related deaths: findings from a modelling study. Nielsen S., Scott N., Tidhar T., Quiroga M.D.M., Lenton S., Dietze P., p. 1009-1019.
- Impact of wagering inducements on the gambling behaviors of on-line gamblers: A longitudinal study based on gambling tracking data. Balem M., Perrot B., Hardouin J.-B., Thiabaud E., Saillard A., Grall-Bronnec M., et al., p. 1020-1034.
- Effectiveness of an optimized text message and Internet intervention for smoking cessation: A randomized controlled trial. Graham A.L., Papandonatos G.D., Cha S., Amato M.S., Jacobs M.A., Cohn A.M., et al., p. 1035-1046.
- Commentary on Graham et al.: Biochemical verification of abstinence in remotely conducted smoking cessation trials should not be a universal design requirement for rigor. Heffner J.L., McClure J.B., p. 1047-1048.
- Long-term associations of cigarette smoking in early mid-life with predicted brain aging from mid- to late life. Whitsel N., Reynolds C.A., Buchholz E.J., Pahlen S., Pearce R.C., Hatton S.N., et al., p. 1049-1059.
- Commentary on Whitsel et al.: Smoking, alcohol use and the brain- the challenge of answering causal questions. Treur J.L., p. 1060-1061.
- Panoramic smoking burden and genetic susceptibility in relation to all-cause and cause-specific mortality: a prospective study in UK Biobank. Song Q., Zhou T., Sun D., Ma H., Li X., Heianza Y., et al., p. 1062-1070.
- Polygenic score for cigarette smoking is associated with ever electronic-cigarette use in a college-aged sample. Cooke M.E., Clifford J.S., Do E.K., Gilman J.M., Maes H.H., Peterson R.E., et al., p. 1071-1078.
- Effectiveness of offering tailored text message, self-help smoking cessation support to pregnant women who want information on stopping smoking: MiQuit3 randomised controlled trial and meta-analysis. Coleman T., Clark M., Welch C., Whitemore R., Leonardi-Bee J., Cooper S., et al., p. 1079-1094.
- Strategies to enhance the effects of pictorial warnings for cigarettes: results from a discrete choice experiment. Thrasher J.F., Islam F., Arillo-Santillan E., Rodriguez-Bolanos R., Saenz de Miera Juarez B., Hardin J.W., et al., p. 1095-1104.
- Are market mechanisms associated with alcohol and other drug treatment outcomes? Ritter A., van de Ven K., Vuong T., Chalmers J., Dobbins T., Livingston M., et al., p. 1105-1116.
- Alcohol and nicotine polygenic scores are associated with the development of alcohol and nicotine use problems from adolescence to young adulthood. Deak J.D., Clark D.A., Liu M., Schaefer J.D., Jang S.K., Durbin C.E., et al., p. 1117-1127.
- Tobacco use disorder and cardiovascular health. Benowitz N.L., Liakoni E., p. 1128-1138.
- The science of recovery capital: where do we go from here? Best D., Hennessy E.A., p. 1139-1145.
- Langer's illusion of control and the cognitive model of disordered gambling. Clark L., Wohl M.J.A., p. 1146-1151.
- Preventing Overdose Using Information and Data from the Environment (PROVIDENT): protocol for a randomized, population-based, community intervention trial. Marshall B.D.L., Alexander-Scott N., Yedinak J.L., Hallowell B.D., Goedel W.C., Allen B., et al., p. 1152-1162.
- Exploring the implementation of public involvement in local alcohol availability policy: the case of alcohol licensing decision-making in England. David G., Cooper R., Dixon S., Holmes J., p. 1163-1172.
- Increasing opium use in Iran in response to unsubstantiated rumors that it protects against COVID-19. Khosravi M., p. 1173-1174.
- There is no causality in the 'gateway hypothesis': another test gone amiss. Vanyukov M.M., p. 1174-1175.
- Response to Vanyukov: Why causality is a valid question for the gateway hypothesis. Reed Z.E., Wootton R.E., Munafò M.R., p. 1175-1176.
- Increased illicit substance use among Zimbabwean adolescents and youths during the COVID-19 era: an impending public health disaster. Mukwenha S., Murewanhema G., Madziva R., Dzinamarira T., Herrera H., Musuka G., p. 1177-1178.